CYNAGRA
CYROX
CECAL
CYFLOX-200
CYFLOX-400
LECOURSE-500
CYPAN
CYPAN-D
NOM
TRACE
GINCER
     
 
 
 
 
 
 
Pharmacology of Drug-Tranexamic Acid
 
       
  Mechanism of Action

Tranexamic acid exerts antifibrinolytic effect by forming a reversible complex with plasminogen through the lysine binding site of fibrin and thus displaces the plasminogen from the fibrin surface ; preventing the binding of plasmin to fibrinogen or fibrin monomers. It inhibits the activation of plasminogen (i.e. formation of plasmin). It also acts as a weak non competitive inhibitor of plasmin and blocks it`s action on fibrin.
 
  Pharmaco Kinetics
Absorption: About 40% is absorbed orally. Distribution: Widely distributed in the body. Excretion: Excreted mainly as unchanged drug.
 
  Half Life
2 hours
 
  Adverse Effects
1.Nausea  2.Diarrhoea  3.Gastrointestinal problems  4.Headache 5.Hypotension  6.Giddiness  7.Thrombophlebitis at injected vein 8.Impairment of Colour vision
 
  ContraIndications
1.Thromboembolic disorders  2.Subarachnoid haemorrhage 3.Massive upper urinary tract haemorrhage  4.Colour vision disorders  5.Thrombophlebitis  6.Hepatic impairment  7.Severe renal impairment
 
  Special Precautions
1.Avoid rapid I.V. administration  2.Lower dosage adjustment is required in renal impairment  3.Monitor liver functioning during long term use
 
  Pregnancy
Contraindicated
 
  Breast Feeding
Use with caution
 
  Old Age
Use with caution
 
  Indications
1.Surgical procedures  2.Menorrhagia  3. Metrorrhagia  4.Post partum haemorrhage  5.Haemorrhage after abortion 6.Haemorrhage due to contraceptive device insertion  7.Tooth extractions and haemorrhage in other dental procedures 8.Epistaxis  9.Haemoptysis  10.Gastrointestinal bleeding 11.Prostatectomy  12.Tonsillectomy  13.Fibrinolysis  14.Ocular trauma  15.Orthopedic surgery  16.Cardiovascular surgery
 
  Dosage  
Oral: 3 to 4gm/day in 3 to 4 divided doses or 15 to 25mg/kg body wt. 3 to 4 times daily.  I.V.: 1.5 to 3gm/day in 3 divided doses or 10 to 15mg/kg body wt. 3 times daily. Administered as slow I.V. injection or as continuous infusion; at a rate of 25 to 50mg/kg/day.
 
  Storage  
Store below 25 degree C. and protects from light. Keep out of reach of children.
 
  Over Dose  
Treatment is supportive and symptomatic. Remove drug from the body by induced emesis, gastric lavage and administer activated charcoal to reduce absorption. Maintain adequate diuresis with the aid of fluids and diuretics.